Mobile

A phase II, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of UK-500,001 Dry Powder for Inhalation (DPI) in adults with moderate to severe Chron...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003713-32

A phase II, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of UK-500,001 Dry Powder for Inhalation (DPI) in adults with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy and safety/tolerability of UK-500,001 DPI in adults with moderate to severe COPD (Global initiative in Obstructive Lung Disease [GOLD] stage II/III).

Critère d'inclusion

  • Chronic Obstructive Pulmonary Disease (COPD)

Liens